ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL CANCER INSTITUTE

NCTN Deep South Research Consortium

Completed
Institution
University of Alabama at Birmingham, AL
Principal investigator
Charles A. Leath
Funding
$451K
Duration
2019–2026
Open portfolio

Moonbase score

Still being scored

Abstract

ABSTRACT The University of Alabama at Birmingham (UAB) O’Neal Comprehensive Cancer Center (O’Neal) has a long history of participation within the National Clinical Trials Network. Specifically, UAB was a founding member of GOG, and has been a member of RTOG, ECOG, ACRIN, CALGB, NSABP, and SWOG. O’Neal is a current member of the ECOG-ACRIN, NRG, and SWOG cooperative groups. It is our intention to continue as a leading contributor of scientific leaders and clinical trial participants to the NCTN Program in the U.S. and particularly in the Southeast. To accomplish this overall vision, we propose to further enhance the involvement of existing O’Neal leadership in NCTN Center related clinical and translational research and to develop the next generation of NCTN Center scientific leaders within O’Neal. In addition, we will further refine a clinical trials process within O’Neal that optimizes accrual of potentially eligible cancer patients and patients at risk for cancer to NCTN Center clinical trials. Finally, we will increase minority accrual to NCTN Cooperative Group trials though our patient population.

Research team

  • Charles A. LeathPI
  • Andrew M McdonaldPI
  • Amitkumar N MehtaPI
  • Erica Michelle Stringer-ReasorPI

LOADING MOONBASE SCORE

NATIONAL CANCER INSTITUTEUG1membercooperativeaccrualnctnuabswogscientific leadersneal

Questions for University of Alabama at Birmingham

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.